TECH Bio-Techne
Nasdaq · SEC CIK 842023 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $437.2K 2 sales by 1 insiders
- Filings on record
- 188 since 2021-07-14, latest 2026-09-24 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Herr Amy E. | Dir | — | $437.2K |
| Crouse Steven C. | Pres - Diag, Spatial Bi | — | — |
| Bohnen Shane | SVP - GC | — | — |
| McManus Matthew | Pres - Diag, Spatial Bio | — | — |
| Geist William | Pres, PROTEIN SCIENCES | — | — |
| Klimovsky Judith V. | Dir | — | — |
| Kelderman Kim | CEO, Dir | — | — |
| Seth Alpna | Dir | — | — |
| Vessey Rupert | Dir | — | — |
| Hippel James | CFO | — | — |
Transactions 246
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-28 | 2024-10-24 | TECH | KEEGAN JOSEPH D | Dir | A - Grant | $0.00 | +1,462 | 13.8K | +12% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +1,462 | 48.2K | +3% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | Bushman Julie L | Dir | A - Grant | $0.00 | +1,462 | 7,135 | +26% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | Seth Alpna | Dir | A - Grant | $0.00 | +1,462 | 13.8K | +12% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | Nusse Roeland | Dir | A - Grant | $0.00 | +1,462 | 44.6K | +3% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | Klimovsky Judith V | Dir | A - Grant | $0.00 | +1,462 | 2,142 | +215% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | BAUMGARTNER ROBERT V | Dir | A - Grant | $0.00 | +1,462 | 44.9K | +3% | $0 |
| D | 2024-10-28 | 2024-10-24 | TECH | VESSEY RUPERT | Dir | A - Grant | $0.00 | +1,462 | 9,347 | +19% | $0 |
| D | 2024-09-16 | 2024-09-12 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $22.95 | +6,000 | 48.6K | +14% | +$137.7K |
| D | 2024-09-16 | 2024-09-12 | TECH | HIGGINS JOHN L | Dir | F - Tax | $73.20 | -1,874 | 46.7K | -4% | -$137.2K |
| D | 2024-09-03 | 2024-08-29 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $66.97 | +1,492 | 41.4K | +4% | +$99.9K |
| D | 2024-08-19 | 2024-08-15 | TECH | Bohnen Shane | SVP - GC | F - Tax | $74.91 | -15 | 1,681 | -0.9% | -$1,124 |
| D | 2024-08-19 | 2024-08-15 | TECH | Bohnen Shane | SVP - GC | M - OptEx | $0.00 | +49 | 1,696 | +3% | $0 |
| D | 2024-08-12 | 2024-08-08 | TECH | BAUMGARTNER ROBERT V | Dir | S - Sale+OE | $72.10 | -16.0K | 43.4K | -27% | -$1.15M |
| D | 2024-08-12 | 2024-08-08 | TECH | BAUMGARTNER ROBERT V | Dir | M - OptEx | $22.95 | +16.0K | 59.4K | +37% | +$367.2K |
| D | 2024-08-06 | 2024-08-02 | TECH | Hippel James | CFO | F - Tax | $82.35 | -36.1K | 99.9K | -27% | -$2.97M |
| D | 2024-08-06 | 2024-08-02 | TECH | Hippel James | CFO | M - OptEx | $31.26 | +53.0K | 136.0K | +64% | +$1.66M |
| D | 2024-08-02 | 2024-07-31 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $81.97 | -9,479 | 39.9K | -19% | -$777.0K |
| D | 2024-08-02 | 2024-07-31 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $37.70 | +14.0K | 49.4K | +40% | +$527.8K |
| D | 2024-07-25 | 2024-07-23 | TECH | Hippel James | CFO | M - OptEx | $31.26 | +35.0K | 107.3K | +48% | +$1.09M |
| D | 2024-07-25 | 2024-07-23 | TECH | Hippel James | CFO | F - Tax | $77.77 | -24.3K | 83.0K | -23% | -$1.89M |
| D | 2024-07-10 | 2024-07-08 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $22.95 | +6,000 | 42.6K | +16% | +$137.7K |
| D | 2024-05-16 | 2024-05-14 | TECH | HIGGINS JOHN L | Dir | S - Sale+OE | $83.84 | -4,000 | 36.6K | -10% | -$335.4K |
| D | 2024-05-16 | 2024-05-14 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $22.95 | +4,000 | 40.6K | +11% | +$91.8K |
| D | 2024-05-03 | 2024-05-01 | TECH | Klimovsky Judith V | Dir | A - Grant | $0.00 | +680 | 680 | New | $0 |
| D | 2024-04-05 | 2024-04-03 | TECH | Bohnen Shane | SVP - GC | M - OptEx | — | +2,259 | 2,394 | +1,673% | — |
| D | 2024-04-05 | 2024-04-03 | TECH | Bohnen Shane | SVP - GC | F - Tax | $67.87 | -747 | 1,647 | -31% | -$50.7K |
| 2024-03-11 | 2024-03-07 | TECH | Nusse Roeland | Dir | S - Sale | $76.98 | -10.4K | 43.1K | -19% | -$800.6K | |
| 2024-02-05 | 2024-02-01 | TECH | Geist William | Pres, PROTEIN SCIENCES | F - Tax | $68.54 | -1,111 | 7,759 | -13% | -$76.1K | |
| D | 2023-12-21 | 2023-12-19 | TECH | Hippel James | CFO | F - Tax | $77.42 | -33.0K | 71.9K | -31% | -$2.55M |
| D | 2023-12-21 | 2023-12-19 | TECH | Hippel James | CFO | M - OptEx | $31.26 | +47.3K | 104.8K | +82% | +$1.48M |
| D | 2023-11-03 | 2023-11-01 | TECH | Kelderman Kim | COO | A - Grant | $0.00 | +14.2K | 35.4K | +67% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | Bushman Julie L | Dir | A - Grant | $0.00 | +1,625 | 5,673 | +40% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | Seth Alpna | Dir | A - Grant | $0.00 | +1,625 | 12.3K | +15% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | KEEGAN JOSEPH D | Dir | A - Grant | $0.00 | +1,625 | 12.3K | +15% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | VESSEY RUPERT | Dir | A - Grant | $0.00 | +1,625 | 7,885 | +26% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | Nusse Roeland | Dir | A - Grant | $0.00 | +1,625 | 53.5K | +3% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | BAUMGARTNER ROBERT V | Dir | A - Grant | $0.00 | +1,625 | 43.4K | +4% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | STEER RANDOLPH C | Dir | A - Grant | $0.00 | +1,625 | 24.2K | +7% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +1,625 | 36.6K | +5% | $0 |
| DM | 2023-09-01 | 2023-08-30 | TECH | Nusse Roeland | Dir | M - OptEx | $22.40 | +32.0K | 44.8K | +250% | +$716.8K |
| D | 2023-09-01 | 2023-08-30 | TECH | Nusse Roeland | Dir | S - Sale+OE | $80.32 | -8,939 | 51.9K | -15% | -$718.0K |
| D | 2023-08-28 | 2023-08-24 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $47.60 | +2,100 | 21.2K | +11% | +$100.0K |
| D | 2023-08-17 | 2023-08-15 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $84.61 | -8,675 | 1.28M | -0.7% | -$734.0K |
| D | 2023-08-17 | 2023-08-15 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | +17.6K | 1.29M | +1% | $0 |
| 2023-08-11 | 2023-08-09 | TECH | Kummeth Charles R. | CEO, Dir | G - Gift | $0.00 | -9,008 | 1.27M | -0.7% | $0 | |
| D | 2023-08-08 | 2023-08-05 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | +51.5K | 1.31M | +4% | $0 |
| D | 2023-08-08 | 2023-08-05 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $82.17 | -32.0K | 1.28M | -2% | -$2.63M |
| D | 2023-08-08 | 2023-08-05 | TECH | Hippel James | CFO | F - Tax | $82.17 | -6,335 | 57.6K | -10% | -$520.5K |
| D | 2023-08-08 | 2023-08-05 | TECH | Hippel James | CFO | M - OptEx | $0.00 | +12.9K | 63.9K | +25% | $0 |
| D | 2023-08-08 | 2023-08-05 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +8,060 | 23.3K | +53% | $0 |
| D | 2023-08-08 | 2023-08-05 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $82.17 | -4,139 | 19.1K | -18% | -$340.1K |
| 2023-07-25 | 2023-07-21 | TECH | Kummeth Charles R. | CEO, Dir | S - Sale | $88.36 | -80.0K | 1.26M | -6% | -$7.07M | |
| D | 2023-07-05 | 2023-06-30 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $26.65 | +616.7K | 1.73M | +55% | +$16.43M |
| D | 2023-07-05 | 2023-06-30 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $81.63 | -390.7K | 1.34M | -23% | -$31.90M |
| 2023-06-09 | 2023-06-07 | TECH | Kummeth Charles R. | CEO, Dir | S - Sale | $83.00 | -322 | 1.11M | -0.0% | -$26.7K | |
| D | 2023-05-02 | 2023-04-28 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $21.85 | +16.0K | 39.4K | +68% | +$349.6K |
| D | 2023-05-02 | 2023-04-28 | TECH | HIGGINS JOHN L | Dir | F - Tax | $79.88 | -4,377 | 35.0K | -11% | -$349.6K |
| 2023-04-21 | 2023-04-19 | TECH | Nusse Roeland | Dir | G - Gift | $0.00 | -377 | 28.8K | -1% | $0 | |
| D | 2023-01-06 | 2023-01-04 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $26.65 | +407.4K | 1.37M | +42% | +$10.86M |
| D | 2023-01-06 | 2023-01-04 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $84.39 | -255.8K | 1.11M | -19% | -$21.59M |
| DM | 2022-12-09 | 2022-12-07+ | TECH | Furlow Brenda S. | SVP - GC | S - Sale+OE | $82.11 | -8,250 | 26.1K | -24% | -$677.4K |
| DM | 2022-12-09 | 2022-12-07+ | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $31.26 | +8,250 | 26.9K | +44% | +$257.9K |
| D | 2022-10-31 | 2022-10-27 | TECH | KEEGAN JOSEPH D | Dir | A - Grant | $0.00 | +338 | 2,671 | +14% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | Seth Alpna | Dir | A - Grant | $0.00 | +338 | 2,671 | +14% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +338 | 5,840 | +6% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | BAUMGARTNER ROBERT V | Dir | A - Grant | $0.00 | +338 | 10.4K | +3% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | STEER RANDOLPH C | Dir | A - Grant | $0.00 | +338 | 5,644 | +6% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | Bushman Julie L | Dir | A - Grant | $0.00 | +338 | 1,012 | +50% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | Nusse Roeland | Dir | A - Grant | $0.00 | +338 | 7,297 | +5% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | VESSEY RUPERT | Dir | A - Grant | $0.00 | +338 | 1,565 | +28% | $0 |
| D | 2022-08-25 | 2022-08-23 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +663 | 3,801 | +21% | +$100.0K |
| DM | 2022-08-12 | 2022-08-10+ | TECH | HIGGINS JOHN L | Dir | S - Sale+OE | $378.80 | -2,504 | 7,106 | -26% | -$948.5K |
| D | 2022-08-12 | 2022-08-10 | TECH | HIGGINS JOHN L | Dir | M - OptEx | $66.90 | +3,400 | 8,006 | +74% | +$227.5K |
| D | 2022-08-10 | 2022-08-08 | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $177.32 | +563 | 6,523 | +9% | +$99.8K |
| D | 2022-08-09 | 2022-08-07 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +2,363 | 4,352 | +119% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $382.97 | -1,214 | 3,138 | -28% | -$464.9K |
| D | 2022-08-09 | 2022-08-07 | TECH | Hippel James | CFO | M - OptEx | $0.00 | +3,938 | 14.7K | +37% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Hippel James | CFO | F - Tax | $382.97 | -1,938 | 12.8K | -13% | -$742.2K |
| DM | 2022-08-09 | 2021-10-26 | TECH | Furlow Brenda S. | SVP - GC | G - Gift | $0.00 | -2,660 | 6,290 | -30% | $0 |
| DMI | 2022-08-09 | 2021-10-26 | TECH | Furlow Brenda S. | SVP - GC | G - Gift | $0.00 | +2,660 | 1,330 | New | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $0.00 | +1,969 | 6,929 | +40% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Furlow Brenda S. | SVP - GC | F - Tax | $382.97 | -969 | 5,960 | -14% | -$371.1K |
| D | 2022-08-09 | 2022-08-07 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | +16.9K | 252.0K | +7% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $382.97 | -11.6K | 240.4K | -5% | -$4.43M |
| D | 2022-08-01 | 2022-07-28 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $380.76 | -27.7K | 235.0K | -11% | -$10.55M |
| D | 2022-08-01 | 2022-07-28 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $108.49 | +45.3K | 262.7K | +21% | +$4.92M |
| D | 2022-07-08 | 2022-07-06 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $108.49 | +50.0K | 248.3K | +25% | +$5.42M |
| D | 2022-07-08 | 2022-07-06 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $362.78 | -30.9K | 217.4K | -12% | -$11.22M |
| D | 2022-06-09 | 2022-06-07 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $108.49 | +5,104 | 203.4K | +3% | +$553.7K |
| D | 2022-06-09 | 2022-06-07 | TECH | Kummeth Charles R. | CEO, Dir | S - Sale+OE | $365.00 | -5,104 | 198.3K | -3% | -$1.86M |
| DM | 2022-06-09 | 2022-06-07+ | TECH | HIGGINS JOHN L | Dir | S - Sale+OE | $364.98 | -1,600 | 4,606 | -26% | -$584.0K |
| DM | 2022-06-09 | 2022-06-07+ | TECH | HIGGINS JOHN L | Dir | M - OptEx | $66.90 | +1,600 | 5,206 | +44% | +$107.0K |
| 2022-05-11 | 2022-05-10 | TECH | BAUMGARTNER ROBERT V | Dir | P - Purchase | $352.55 | +300 | 10.1K | +3% | +$105.8K | |
| D | 2022-02-10 | 2022-02-08 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +1,989 | 1,989 | New | +$299.9K |
| D | 2022-02-03 | 2022-02-01 | TECH | Geist William | Pres, Protein Sciences | A - Grant | $0.00 | +2,490 | 2,490 | New | $0 |
| DM | 2022-02-01 | 2022-01-28 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $115.08 | +1,737 | 198.3K | +0.9% | +$199.9K |
| DM | 2021-11-23 | 2021-11-19 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | S - Sale+OE | $505.38 | -500 | 400 | -56% | -$252.7K |
| D | 2021-11-23 | 2021-11-19 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +500 | 500 | New | +$75.4K |
| DM | 2021-11-16 | 2021-11-12 | TECH | Eansor Norman David | Pres-Protein Sciences | S - Sale+OE | $504.00 | -27.2K | 27.3K | -50% | -$13.69M |
Purchase Sale Sale after option exercise All abbreviations